What are the implications of 7 waves in a Brainstem Evoked Response Audiometry (BERA) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

BERA 7 Waves: Clinical Interpretation

Normal BERA Waveform Structure

A standard Brainstem Evoked Response Audiometry (BERA) test typically generates 5 distinct waves (labeled I through V), not 7 waves. The presence of 7 waves in a BERA recording is not a standard finding and requires careful technical and clinical evaluation 1.

Standard BERA Wave Components

The normal BERA waveform consists of:

  • Wave I: Generated by the distal portion of cranial nerve VIII (auditory nerve) 1
  • Wave II: Proximal cranial nerve VIII 1
  • Wave III: Cochlear nucleus and lower pons 1
  • Wave IV: Superior olivary complex 1
  • Wave V: Lateral lemniscus and inferior colliculus (most clinically important wave) 1

Wave V is the most critical landmark for clinical interpretation, as its absence predicts poor neurological outcome in conditions like post-cardiac arrest (0% false positive rate for poor outcome when absent during therapeutic hypothermia) 1.

Interpretation of "7 Waves"

Technical Considerations

If 7 distinct peaks are identified on a BERA recording, consider:

  • Artifact contamination: Electrical noise, muscle activity, or environmental interference can create spurious peaks that mimic true brainstem responses 1
  • Stimulus artifact: The initial deflection from the acoustic click stimulus itself is not counted as a true wave 2, 3
  • Middle-latency responses: Waves VI and VII represent middle-latency auditory evoked potentials (occurring 10-50 ms post-stimulus) rather than brainstem responses, reflecting thalamocortical pathways 1

Clinical Scenarios

In newborn hearing screening, BERA should demonstrate clear waves I, III, and V with normal interpeak latencies; threshold responses in normal-term infants lie between 10-20 dB hearing level 2. The presence of additional peaks beyond wave V does not enhance diagnostic accuracy for hearing loss detection 2, 4.

For retrocochlear pathology assessment (acoustic neuroma, multiple sclerosis, brainstem lesions), BERA has 98% success rate in detecting cerebellopontine angle lesions based on standard 5-wave analysis with attention to interpeak latencies and wave morphology 3. Additional waves do not improve diagnostic yield 3.

Clinical Applications and Limitations

Appropriate Use of BERA

  • Hearing threshold estimation: Frequency-specific tone-burst ABR provides objective hearing assessment in infants who cannot perform behavioral audiometry 1
  • Brainstem pathway integrity: The Index of Brainstem Conduction (IBSC) derived from BERA reflects medullary, pontine, and midbrain function 1
  • Neurological prognostication: Absence of wave V during therapeutic hypothermia after cardiac arrest predicts poor outcome with high specificity 1

Key Pitfall to Avoid

Do not over-interpret additional peaks beyond the standard 5 waves as pathological findings without first ruling out technical artifacts and ensuring proper recording technique 1. The clinical significance of BERA lies in the latencies and amplitudes of waves I, III, and V, not in the total number of visible deflections 2, 3.

Recommended Approach

When encountering a BERA report describing 7 waves:

  1. Verify recording technique: Confirm proper electrode placement, stimulus parameters (click vs. tone burst), and filtering settings 1, 2
  2. Identify the 5 standard waves: Focus clinical interpretation on waves I, III, and V with their interpeak latencies (I-III, III-V, I-V intervals) 3
  3. Assess for artifacts: Review raw waveforms for electrical noise, muscle contamination, or stimulus artifact 1
  4. Correlate with clinical context: BERA findings must align with behavioral audiometry results in children over 6 months and clinical examination findings 1

For ototoxicity monitoring after platinum-based chemotherapy exposure, serial BERA/ABR testing should focus on threshold shifts and wave V latency prolongation rather than wave morphology changes 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Brain stem evoked response audiometry in newborn hearing screening.

Archives of otolaryngology (Chicago, Ill. : 1960), 1979

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.